UB partners with University of the West Indies to form new disease research centers

Members of the Jamaica Health Ministry and the University of the West Indies met with the University of Buffalo (UB) and SUNY faculty, to begin exploring ways to share research and clinical findings to help both countries. The meeting was focused on instituting a new center to study infectious diseases and engage in team science and collaborative research to achieve sustainable health in the Caribbean region. Though the center will be based in Jamaica, it will also have a presence in Buffalo, possibly at the UB Center of Excellence in Bioinformatics & Life Sciences.

Reference Link: http://www.buffalo.edu/news/releases/2019/04/012.html

Is it necessary to publish papers to obtain your PhD?

Publishing paper would be cherry on pie to build an academic career. Publication is a prerequisite for obtaining your PhD. A well-known phrase “Publish or perish” justifies this statement. Although it sounds dulcet, you need to take utmost care at every single step. If you are wondering, how to achieve your goal, here are a couple of points to ease your muddle.

Research

The first step to achieve your goal should focus on deep research about various papers, journals, publishers. This will help you to pick up the appropriate decision. The lack of research may end up selecting an inappropriate journal which may throw you in the backward direction of your goal. Hence, it is advisable to do thorough research before jumping into a conclusion.

Quality over Quantity

It is said, “Quality takes time but reduces the quantity”. You should spend time developing significant research agendas rather than spending more time scrambling to publish whatever you can get. For example, 1 research paper with novel findings and own interpretation can scoot over 10 review papers. So, don’t rush up on writing more papers as there is no guarantee that writing 10 papers would award you with your degree.

Face your fear

As a beginner, it is obvious to be anxious about the result. However, keep in mind that, “Failure always leads to greater achievements”. Keep yourself calm and composed and don’t force yourself to implant negative thinks.  These negative thinking will divert you to take the decision of writing it with a co-author. I am not against this statement but this decision might affect you in a later state.

 Be ready

No one in this world is perfect so don’t let your ego come in between achieving your goal. You should be confident enough about your research paper. It is better if you could make it proofread by someone to pick up the flaws prior to submission. Several companies are there which provide such services thereby helping you completing the research error-free.

Manage your emotions  

It is quite necessary to manage the time from the beginning with great patience as you had to research all the details minutely within the stipulated time. You can also seek the help of your guide to review it and suggest you with certain actions.

Conclusion

Obtaining PhD through publication is not only an option available for doctoral candidates. In order to achieve your goal, you must work hard and present strong research with novel findings. The candidate who easily accepts the flaws and decodes it further in their work will go a long way.

East African Community launches provincial journal

The East African Science and Technology Commission or EASTECO has launched a local journal to promote research in science, technology and innovation. This is a step forward to improve sharing knowledge among the scientific community. The most interesting thing is that this is the first journal of its kind in the region. It is funded by six EAC states. EASTECO’s executive sectary, Gertrude Ngabirano said they aim new information which can be used to address issues disturbing the region. It will also help come up with evidence-based policies.

Reference Link: https://www.newvision.co.ug/new_vision/news/1497716/eac-launch-regional-science-journal-promote-research-innovation

Open Access Publishing hasn’t fulfilled its promises

The New England Journal of Medicine or NEJM thinks open-access is not a good idea. An editorial published by Charlotte Haug, one of the correspondents of NEJM reports that the “experiment” has failed, and free access to scientific publications hasn’t delivered on its promises. NEJM is particularly concerned about “Plan S”, a plan in Europe that suggests that all scientists whose work is funded by the community be required to publish their results in open-access venues. Plan S is due to take upshot in 2020.

Reference Link: https://www.forbes.com/sites/stevensalzberg/2019/04/01/nejm-says-open-access-publishing-has-failed-right/#59541d546a44

Future Science Group opens a new journal – Future Drug Discovery

Future Drug Discovery is a peer-reviewed, open access journal covering the latest breakthrough science in drug discovery, research & development. Future Drug Discovery aims to harness high failure rates, presenting new advances and discussing their applications and translation in an openly accessible format, and providing a forum for discussing the field at large. It will be a quarterly publication publishing case histories, methodologies, original research, reviews and opinion articles covering the entire drug discovery pipeline, plus topics of interest to the drug discovery community. A comprehensive list of topics can be found at the journal webpage.

Reference Link: https://www.eurekalert.org/pub_releases/2019-03/fsg-fsg032619.php

Big pharma cuddles open-access publishers

According to a study, scientists from pharmaceutical trade publish a higher fraction of their papers open access than academics who aren’t in industry. The open-access papers published by 23 large drug companies, such as Pfizer and Roche has overtaken the quantity of liberally available papers published most prominently in medicine-related fields.“It seems like big pharma has a notable niche in open access,” says Kyle Siler, a social scientist at Utrecht University in the Netherlands.

UC terminates negotiation with publishing giant Elsevier

As a leader in the universal movement toward open access to publicly funded research, the University of California terminated its further subscriptions with Elsevier, the world’s largest scientific publisher. Despite months of bond negotiations, Elsevier was reluctant to meet UC’s key goal: acquiring universal open access to UC research to enable users to view it excluding any charges- as well as to restrain the rising costs associated with for-profit journals. Under Elsevier’s new proposed terms, the publisher would have charged UC authors large publication fees on top of the university’s multi-million dollar subscription, subsequently increasing the cost to the University and greater profits for Elsevier.

Reference link: https://news.berkeley.edu/2019/02/28/why-uc-split-with-publishing-giant-elsevier/

Bristol University pledge a breakthrough in ensuring 5G networks security

New research carried out by the High-Performance Networks Research Group at the University of Bristol’s Smart Internet Lab, has validated a groundbreaking solution for the concerns on security susceptibility of 5G networks which are anticipated to transform the telecommunication industry. The findings were presented on 7 March at a highly prestigious post-deadline paper in the Optical Fibre Communication Conference, San Diego, USA. The proposed solution will enable 5G network operators to offer ultimately secure 5G services while assuring ultra-low-latency and high-bandwidth communications. This is due to the unique blend of quantum and infrastructure virtualization technologies.

Reference link: http://bristol.ac.uk/news/2019/march/quantum-cryptography.html

Africa’s approach to disease research

Researchers of the Nigeria Centre for Disease Control (NCDC) in Ahuja, and its director general, Chikwe Ihekweazu are building strategies to fight infectious diseases that are more often than not outbreaks in Africa. NCDC’s approach to disease research in Africa is self-assured and revolutionary. The agency is assisting to shape the priorities of international scientists who wish to conduct research in Nigeria. Nigeria is vital, as the nation is massive and the country is poked with outbreaks like Ebola that could crash Africa’s economy and spread worldwide. Supporting African-led research is good for science, good for Africa and good for the entire world.

Reference link: https://www.nature.com/articles/d41586-019-00612-0

CPhI grades Japan in the second position for Pharma

Industry supervisors envisage Japan to be the second fastest growing mature marketplace for solid dose drugs in 2019 followed by the United States. The findings represent a considerable year-on-year improvement in outlook for pharma in Japan with expected growth of solid dose formulations improving by more than 10% with generic drug classes highlighted Significantly, it ranks ahead of all EU nations and Korea. The report concludes that Japan is a ripened country for growth across a number of product classes, but the enduring winners of regulatory changes and innovative R&D remain hard to pick.

Reference Link: https://biospectrumasia.com/news/50/12865/japan-second-fastest-pharma-growth-in-2019-cphi-report.html